These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2855317)

  • 1. Influence of the interaction of calcitonin and 1,25(OH)2-vitamin D3 on prolactin secretion.
    Zofková I; Nedvídková J
    Exp Clin Endocrinol; 1988 Mar; 92(3):262-7. PubMed ID: 2855317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of calcitonin, 1,25(OH)2 vitamin D3 and trifluoperazine on thyrotropic secretion and their mutual interactions.
    Zofková I; Bednár J
    Exp Clin Endocrinol; 1988 Mar; 92(3):268-74. PubMed ID: 3150956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1,25-dihydroxyvitamin D3 (calcitriol) on prolactin secretion at rest and TRH-stimulated secretion in humans.
    Zofková I; Nedvídková J
    Exp Clin Endocrinol; 1988 May; 91(2):207-11. PubMed ID: 3137083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of calcitonin and 1,25(OH)2-vitamin D3 on the FSH, LH and testosterone secretion at rest and LHRH stimulated secretion.
    Zofková I; Scholz G; Stárka L
    Horm Metab Res; 1989 Dec; 21(12):682-5. PubMed ID: 2515139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1.25 (OH)2 vitamin D3 (calcitriol) on TRH-induced thyrotropin secretion in man.
    Zofková I; Bednár J
    Exp Clin Endocrinol; 1988 Mar; 91(1):7-12. PubMed ID: 3131152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of stimulating effect on thyrotropic and lactotropic secretion during prolonged calcitriol administration.
    Zofková I; Táborský P; Bednár J; Nedvídková J
    Exp Clin Endocrinol; 1992; 99(1):54-6. PubMed ID: 1628699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-Dihydroxyvitamin D3 enhances thyrotropin releasing hormone induced thyrotropin secretion in normal pituitary cells.
    D'Emden MC; Wark JD
    Endocrinology; 1987 Sep; 121(3):1192-4. PubMed ID: 3113918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D-enhanced thyrotrophin release from rat pituitary cells: effects of Ca2+, dihydropyridines and ionomycin.
    d'Emden MC; Wark JD
    J Endocrinol; 1989 Jun; 121(3):441-50. PubMed ID: 2474048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells.
    Atley LM; Lefroy N; Wark JD
    J Endocrinol; 1995 Dec; 147(3):397-404. PubMed ID: 8543909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats.
    Jablonski G; Mortensen BM; Klem KH; Mosekilde L; Danielsen CC; Gordeladze JO
    Calcif Tissue Int; 1995 Nov; 57(5):385-91. PubMed ID: 8564802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin inhibits TRH-induced TSH secretion.
    Zofková I; Bednár J
    Exp Clin Endocrinol; 1984 May; 83(3):263-8. PubMed ID: 6432564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tri-iodothyronine, cortisol and transcriptional inhibitors on vitamin D3-enhanced thyrotrophin secretion by rat pituitary cells in vitro.
    d'Emden MC; Wark JD
    J Endocrinol; 1989 Jun; 121(3):451-8. PubMed ID: 2502597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by 1,25-dihydroxycholecalciferol of the acute change in cytosolic free calcium induced by thyrotropin-releasing hormone in GH4C1 pituitary cells.
    Chisholm JC; Kim S; Tashjian AH
    J Clin Invest; 1988 Mar; 81(3):661-8. PubMed ID: 2830313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M; Hock JM; Gera I; Fonseca J; Poser J; Bevan J; Raisz LG
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcaemia and calcitonin inhibit prolactin secretion.
    Zofková I; Nedvídková J
    Exp Clin Endocrinol; 1984 Dec; 84(3):294-8. PubMed ID: 6441727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trifluoperazine inhibits thyrotropin-releasing hormone-stimulated TSH secretion.
    Zofková I; BednárJ
    Horm Metab Res; 1986 Sep; 18(9):621-4. PubMed ID: 3096861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 1,25-dihydroxyvitamin D3 on rat pituitary prolactin release.
    Törnquist K
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):459-64. PubMed ID: 3425161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.